Brief: Guardant Health Announces Strategic Collaboration With Pfizer To Support Development And Commercialization Of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform
24/04/2025 13:15
April 24 (Reuters) - Guardant Health Inc GH.O: GUARDANT HEALTH ANNOUNCES STRATEGIC COLLABORATION WITH PFIZER TO SUPPORT DEVELOPMENT AND COMMERCIALIZATION OF NEW CANCER THERAPIES USING GUARDANT INFINITY SMART LIQUID BIOPSY PLATFORM GUARDANT HEALTH INC - COLLABORATION PROVIDES PFIZER ACCESS TO GUARDANT TESTS IN CHINA Source text: ID:nBw3L8GL7a Further company coverage: GH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardant Health
See all newsBrief: Guardant Health Announces Approval In Europe Of Guardant360® Cdx
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US Health Secretary Kennedy Jr. adds eight new members to key health committee (updated)
Brief: US FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation
Brief: Guardant Health To Appeal Federal District Court Judgment